BALTIMORE — A decision is due any day from a federal court in Texas that could have sweeping repercussions on abortion access across the country — including in states, like Maryland, where the procedure is protected.
Several anti-abortion groups and doctors are suing the U.S. Food and Drug Administration to revoke its 22-year-old approval of the drug mifepristone, which is used in combination with the drug misoprostol in 98% of medication abortions in the U.S.
Until a ruling is made in the case ― which was filed in November 2022 by the Alliance Defending Freedom legal group ― it remains unclear how the lawsuit will affect Maryland, said Karen Nelson, president and CEO of Planned Parenthood of Maryland.
